Ticagrelor was associated with lifetime quality-adjusted life-year ( QALY ) gains of 0.17 in Sweden , 0.16 in the UK , 0.17 in Germany and 0.13 in Brazil compared with generic clopidogrel , with increased healthcare costs of 467 , 551 , 739 and 574 , respectively .